Cargando…
Adenovirus delivery of encoded monoclonal antibody protects against different types of influenza virus infection
Due to the high mutation and recombination rates of the influenza virus, current clinically licensed influenza vaccines and anti-influenza drugs provide limited protection against the emerging influenza virus epidemic. Therefore, universal influenza vaccines with high efficacy are urgently needed to...
Autores principales: | Wang, Xiang, Zhou, Ping, Wu, Mangteng, Yang, Kaiyan, Guo, Jingao, Wang, Xuchen, Li, Jun, Fang, Zihao, Wang, Guiqin, Xing, Man, Zhou, Dongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347565/ https://www.ncbi.nlm.nih.gov/pubmed/32665862 http://dx.doi.org/10.1038/s41541-020-0206-5 |
Ejemplares similares
-
Intratumoral delivery of a novel oncolytic adenovirus encoding human antibody against PD-1 elicits enhanced antitumor efficacy
por: Zhou, Ping, et al.
Publicado: (2022) -
A bivalent live-attenuated vaccine candidate elicits protective immunity against human adenovirus types 4 and 7
por: Guo, Jingao, et al.
Publicado: (2021) -
Gene therapy for colorectal cancer using adenovirus-mediated full-length antibody, cetuximab
por: Xing, Man, et al.
Publicado: (2016) -
Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China
por: Wang, Xiang, et al.
Publicado: (2014) -
In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
por: Patel, Ami, et al.
Publicado: (2020)